Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children
Abstract Background Selexipag is an orally effective prostacyclin receptor agonist that has been approved for treating pulmonary arterial hypertension (PAH) in adults but is still used off-label in children. This study aimed to evaluate the efficacy and safety of selexipag as part of triple combinat...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-05-01
|
| coleção: | BMC Pediatrics |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12887-026-06954-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|